Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $60.97 ($450,422)
  2. 8-K Event Unregistered share sale · Other events
  3. 4 Open-market sale President & CEO sold 16,700 shares at an average $74.38 ($1,242,213)
  4. 4 Open-market sale Chief Financial Officer sold 12,771 shares at an average $79.13 ($1,010,506)
  5. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $77.66 ($573,670)
  6. SC 13G Stake Amended Statement of Ownership
  7. 8-K Event Executive or director change
  8. 4 Open-market sale Chief Financial Officer sold 60,000 shares at an average $74.15 ($4,448,762)
  9. 4 Open-market sale President & CEO sold 16,700 shares at an average $61.28 ($1,023,340)
  10. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $66.23 ($662,299)
  11. S-3ASR Offering Registration Statement
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $64.63 ($477,439)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale President & CEO sold 16,700 shares at an average $54.57 ($911,245)
  20. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $54.90 ($405,527)

Page 16 of 22 · 421 filings